This emergency department study is one component of the BC Alcohol and Other Drug Monitoring Project. It is an ongoing emergency department study that is currently recruiting patients who come into the ED on one Friday and one Saturday evening per month between 9 p.m. and 4 a.m. at two EDs in British Columbia (Royal Jubilee Hospital in Victoria and Vancouver General Hospital in Vancouver). A pilot study was conducted on 97 patients early in 2008 to test the survey instruments and protocol. As a result, improvements were made to the sampling strategy, the survey instruments, the study protocol and the consent form.
Currently this monitoring study is using ICD-9 because one of our study sites is still using this version of the diagnostic categories in their emergency department. In addition, information obtained from patients in a busy ED is not specific enough to code for the more detailed ICD-10 conditions.
Inclusion Criteria
Interviewees who are between 17 to 75 years of age, can speak and understand English and can provide informed consent are asked to participate. Each respondent completes an interviewer-administered survey, a breathalyzer test and a saliva test for drugs of abuse.
Demographics
Approximately 460 patients participated in between April 2008 and June 2009 (234 in Vancouver and 228 in Victoria). Just over half (51.7%, n=234) of respondents were female compared with 48.1% (n=218) who were male. Respondents were predominately Caucasian (n =296, 67.4%), followed by Aboriginal respondents (n=34, 7.7 %). Just over half of the respondents (n=227, 51.8%) had either full- or part-time employment. Mean age was 39.7 years (range 17-75 years). Almost three quarters of the respondents were born in Canada (n=321, 74.1%). For more information see demographic tables for Vancouver, Victoria and both sites.
Instruments
Patients who consent to be in the study are interviewed using a standardized survey instrument. The survey consists of questions pertaining to the reason for visit, the participant’s drug use history (lifetime use, past 12 months, one month, one week, and yesterday use), including specific alcohol use, cannabis use, and injection drug use. There are questions pertaining to drug-related harms and to alcohol or drug use in the six hours prior to onset of symptoms/injury. Survey instruments were developed for each site: Royal Jubilee Hospital and Vancouver General Hospital.
BAC and Saliva Tests
Participants also consent to a breathalyzer test and a saliva drug test. The breath test used is either the Alco-Sensor IV - Blue Dot or the Alco-Sensor IV FST breathalyzer. For the breathalyzer test, a subject blows into a sterile disposable mouthpiece for 5 to 10 seconds and the machine automatically estimates the BAC. A saliva/sweat drug test is administered, using a Securetec Detektions-Systeme AG Drugwipe5 five-drug sensing test strip. This is a self-contained testing strip which displays the presence of metabolites of drugs via the development of coloured lines in the strip's detection zone: amphetamine-like substances (including amphetamine, methamphetamine, ecstasy), cocaine, opiates (heroin and morphine) and cannabis.
Most respondents consented to the breath alcohol test (n=399, 86.7%) and saliva drug tests (n=400, 88.1 %). Of the 88.1% of respondents that consented to the saliva drug tests, approximately 50.4% (n=195) of them reported using drugs, illicit and or pharmaceutical in the 6 hours prior to their injury or illness; 5.4% (n=21) reported using cannabis in the 6 hours prior to their injury or illness. Of the 86.7% of respondents that consented to a breathalyzer test approximately 25.8% (n=100) reported using alcohol in the 6 hours prior to their injury or illness.
Locations and Partnerships
Two locations are used for this study – Vancouver General Hospital (VGH) in Vancouver and Royal Jubilee Hospital (RJH) in Victoria. VGH is the largest hospital in British Columbia and the major tertiary referral centre for the province. Services in all adult areas of medicine except obstetrics are provided at this site. RJH is one of two tertiary hospitals serving Vancouver Island (Victoria General Hospital is the other). These hospitals operate as one large facility across two sites, providing high-level trauma care and specialized services.
Securing these locations has been made possible by having direct collaboration with key ED medical staff at each site. Drs. Andrew MacPherson at RJH and Jeff Brubacher at VGH have been instrumental in moving this project forward. Other possible sites for expansion include St. Paul’s Hospital in Vancouver and Victoria General Hospital as both sites have shown interest.